습성황반변성에서 광역학치료와 항혈관내피세포성장인자투여 효과

Abstract

Purpose: To compare the effect of photodynamic therapy(PDT) with verteporfin and intravitreal bevacizumab in patient with wet age-related macular degeneration (AMD) Method: Author evaluated 29 eyes 29 patient with wet age-related macular degeneration. The 29 patients were divided two groups: photodynamic therapy group and intravitreal bevacizumab group. Each groups received one of the treatment and the visual acuity was evaluated after three months. Result: There was no significant difference in visual acuity between the effect of photodynamic therapy and intravitreal bevacizumab in patient wet AMD. Conclusion: The photodynamic therapy treatment and intravitreal bevacizumab in patient wet AMD have the similar effect in improvement in visual acuity.